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Abstract 
 
Background and aims: A substantial amount of antibiotic use in hospitals may be inappropriate, 
potentially leading to the development and spread of antibiotic resistance, adverse effects, mortality and 
increased hospital costs. The objective was to assess current patterns of antibiotic use  in a leading 
referral hospital in Western Kenya. This would lead to the identification of opportunities for quality 
improvement in this hospital and across Kenya. Methodology:  A point prevalence survey was carried 
out with data abstracted principally from patient medical records supplemented by interviews from 
physicians when needed. The pattern of antibiotic use was analyzed by descriptive methods. Differences 
in antibiotic use and indications between the selected wards were compared using the Chi-square test or 
)LVKHU¶VH[DFWWHVWVResults:  Among the patients surveyed, 67.7% were on antibiotics. The most 
common classes of antibiotics prescribed were third generation cephalosporins (55%), imidazole 
derivatives like metronidazole (41.8%) and broad spectrum penicillins (41.8%). The most common 
indication for antibiotic use was medical prophylaxis (29%), with local guidelines advocating antibiotic 
prophylaxis in mothers after delivery of their child as well as in neonates with birth asphyxia and low 
weight at birth. Dosing of antibiotics was seen as generally optimal when assessed against current 
recommendations. Conclusion: Whilst the dosing of antibiotics seemed adequate, there was high use of 
antibiotics in this hospital. This needs to be urgently reviewed with current appreciable empiric antibiotic 
use. Programmes are being instigated to address these concerns including developing antibiotic 
guidelines and formularies especially for empiric use as well as implementing antimicrobial stewardship 
activities.  
 
1. INTRODUCTION 
 
Antibiotics are indispensable part of modern medicines and the cornerstone for treating bacterial 
infections across healthcare sectors [1-5].  They are now one of the most common medicines prescribed 
in hospitals and across sectors [1,6,7] to reduce morbidity and mortality [1,2,7,8]. However, there are 
concerns with their overuse, increasing resistance rates as well as increasing morbidity, mortality and 
costs [2,9-13]. Previous studies in Kenya have found a high prevalence of inpatient antibiotic use at 
81.7% [14] and outpatient use at 68.0% to 72.9% of patients [14, 15]. Among 18 hospitals in Egypt, the 
prevalence of antibiotic use was 59% among in-patients [16], and in Nigeria 55.9% of in-patients patients 
were prescribed antibiotics [8]. In China, the prevalence of antibiotic use among in-patients was 56% in a 
recent study [17]. As a result, there is a growing urgency for countries to develop their own action plans to 
improve future antibiotic use, including proactive antibiotic surveillance programs especially in low and 
middle income countries (LMICs), driven by the World Health Organisation and others [8,18-24].  This is 
because a substantial proportion of antibiotics in hospitals may be inappropriate, based on factors such 
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as a lack of any indication or incorrect selection, wrong dosing levels, inappropriate treatment duration or 
multiple prescribing [8,25,26]. Overall, only around 60% of empirically started antibiotics are considered 
appropriate [27].Escherichia coli, Staphylococcus aureus and Klebsiella pneumonia are the three 
organisms of greatest concern associated with both community and hospital acquired infections[28], with 
more recently Pseudomonas aeruginosa, carbapenem-resistant and third-generation cephalosporin-
resistant enterobacteriaceae and meticillin-resistant Staphylococcus aureus a concern [29]. Resistance to 
Klebsiella pneumonia has also been seen in Kenya [30], Concerns with increasing resistance rates 
necessitates urgent action; however, hampered by issues of capacity to undertake sensitivity testing and 
barriers to routine testing [31]. High rates of antibiotic resistance are also seen across Africa, the Middle 
East and Asia, with an appreciable number of WHO regions now reporting high resistance rates leading 
to increased prescribing of second and third line antibiotics [7,32].  
 
Adherence to agreed national guidelines should help improve future antibiotic use and reduce resistance 
rates [7,33,34]. However, there are concerns with current adherence to recommended antibiotic 
treatments and doses for infectious diseases across countries [27, 33-35] although not universal [36], as 
well as a lack of formularies and associated activities in hospitals in Africa to improve future antibiotic use 
[37-39]. In Kenya, currently only 4 in 10 public hospitals were complying with the National treatment 
guidelines when their prescribing was analyzed raising concerns with increasing AMR rates [40]. 
Despite these concerns, there is currently a lack of overall data on antibiotic use e among hospitals in 
Kenya especially Western Kenya. This data is important to help develop pertinent strategies to improve 
the future use of antibiotics in hospitals as part of the National Action Plan on Antibiotic use of Kenya [21], 
especially given the high prevalence of infectious diseases in Western Kenya including HIV [41].  
Consequently as a first step, we sought to conduct a point prevalence survey to quantify antimicrobial 
utilization at Jaramogi Oginga Odinga Teaching and Referral Hospital in the Western region of Kenya. It 
is hoped that this information will serve as a baseline for future point-prevalence surveys in Kenya, as 
well as provide a baseline for developing appropriate antimicrobial stewardship programs and 
interventions in this part of Kenya and wider including guidelines for the empiric use of antibiotics.  
 
2. METHODOLOGY 
 
2.1 Study setting 
The study was carried out at Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH), which 
is the major referral Hospital in Western Kenya, serving a population in excess of 5 million. The hospital is 
located 3.5 miles from the city centre of Kisumu. The hospital has a bed capacity of 467 with bed 
occupancy of 94.8%. 
 
2.2 Study design and target population 
A point prevalence cross-sectional design was employed to determine the variation and characterize the 
current use of antibiotics  in sampled departments in JOOTRH. The Global point prevalence survey 
protocol [42] provided a basis for the forms that were adopted to subsequently evaluate antimicrobial 
prescribing practices in JOOTRH and identify targets for quality improvement. This builds on a similar 
situation for point prevalence studies now being undertaken in Botswana, South Africa and Zimbabwe 
[43-46].  
 
The target population included adult, paediatric, male and female inpatients on antibiotics admitted at 
JOOTRH, with data collection taking place between 5th to 12th June 2017. 
 
2.3 Sampling and eligibility criteria 
Universal sampling was used to select patients. The global PPS method of data collection for patients 
present in the wards was principally applied in the paediatric, surgical, intensive care and newborn units. 
In these departments, patient prescriptions and files were accessed at 2.00 pm. This timing for the survey 
was selected so as to minimize interruption of ward rounds which usually take place in the morning hours. 
However, information about the targeted hospital wards was collected at 8.00 am on the day of survey 
since this timing did not interrupt ward rounds. Due to external factors that were unavoidable including an 
ongoing nurses strike, minor modifications of the Global PPS methodology were made to facilitate data 
collection in medical, gynaecology and postnatal wards, with many patients being discharged from these 
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wards during data collection. Consequently in this instance, files for patients the day before the survey 
were located using the occurrence book and retrieved from the wards and health records department. An 
assumption was made that patients were present in these wards at the time of survey to obtain a better 
picture of current antibiotic use.  
 
Medical records were included if the patient was on any antibiotic at the time of the study, admitted to 
sampled wards at JOOTRH, of any age and sex or had complete records. Records were excluded if the 
patient was an outpatient, was seeking treatment outside JOOTRH or their records were missing.  
 
2.4 Data collection 
Data was collected using two standardized forms adopted from Global point prevalence survey protocol. 
One form collected data about the hospital wards (date of survey, patient population, ward type and 
number of patients on each ward on the day of the survey). The second form was used to collect data 
about each patient included in the survey, i.e. patient demographic characteristics, name of the antibiotics 
prescribed, single unit dose, route, frequency, duration of use, diagnosis and indications. The total daily 
prescribed dose was computed as the product of single unit doses and frequency rather than using 
approaches such as defined daily doses (DDDs).  
 
Two research assistants were recruited to help with data collection. These were clinical officers on 
internships stationed on the wards and trained in data collection. Clinical officers are medical practitioners 
who hold a diploma in clinical medicine, typically referred to as medical assistants in other countries. 
 
2.4.1 Data source 
The principal source for completing data collection was through a review of the patient¶V medical records. 
The treating physician was interviewed if needed for clarification. However, this only happened in a 
minority of situations (10 patient files in total: 3 in the newborn unit, 3 in the surgical ward and 4 in the 
pediatric ward). 
 
2.4.2 Antibiotic usage definitions 
The indications for the antibiotics prescribed were either therapeutic or for prevention (prophylaxis). 
Infections were further divided into community acquired infection and hospital acquired infections. 
Infections were considered as community acquired if symptoms started <48 hours from admission to 
hospital (or present on admission), and hospital acquired if symptoms start 48 hours after admission to 
hospital based on chart review. This could include post-operative surgical site infections (within 30 days 
of surgery or 1 year after implant surgery), hospital acquired pneumonia, and Clostridium difficile 
associated diarrhoea (> 48 hours post admission or <30 days after discharge from previous admission 
episode).  
 
Preventive use, also termed prophylaxis, was further divided into medical or surgical prophylaxis. Medical 
prophylaxis was documented when antibiotics were prescribed to prevent infections in patients with 
medical conditions, e.g. prophylaxis for meningococcal infections, respiratory infections and endocarditis, 
prophylaxis in neutropenic patients or prophylaxis for maternal risk factors. In addition, cotrimoxazole in 
patients with HIV and their long term use to prevent opportunistic infections such as Pneumocystis 
jeruvecii pneumonia. Surgical prophylaxis includes the use of antibiotics to prevent infections at surgical 
sites, with the anatomical site referring to the organ system in which the infection has been identified or 
for prophylactic use. 
 
2.4.3 Prescribing and dispensing of medicines 
Medicines for the hospital are obtained from the Kenya Medical supply agency (KEMSA) and local 
suppliers. For inpatients, treatment sheets are used to obtain prescribed medicines from the Pharmacy. 
The treatment sheets, which lists all medicines patients were taking whilst in hospital, were used to collect 
antibiotic prescription data. The billing of the costs of medicines is undertaken when they are issued, with 
patients required to pay for their medicines and bed charges during discharge.  
 
At time of the study, the hospital did not have a formulary. In addition, there were variable national 
guidelines available as well as some local guidelines such as guidelines for paediatrics, surgery and 
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obstetrics and gynaecology; however, they typically did not contain maximum daily doses for all potential 
antibiotics and indications for the study. Consequently, we used the UK British National Formulary 
(https://www.bnf.org/) to assess the quality of prescribed doses, i.e. to ascertain whether these were 
optimal in line with recommendations from the BNF. The BNF was selected over other possible 
prescribing guidance sources because it was readily available online, and as paper copies and mobile 
applications. Secondly, it is designed as a digest for rapid reference and is easy and convenient to use. In 
addition, the BNF is currently available to pharmacists in Kenya for free via the Pharmaceutical Society of 
Kenya. 
 
The local gynecological guidelines recommend the use of antibiotics for prophylaxis in mothers after 
delivery [47-49]. Basic paediatric protocols in Kenya also recommend antibiotic prophylaxis in neonates 
with birth asphyxia and low body weight at birth [48]. Local guidelines also advocate the use of third 
generation cephalosporins such as ceftriaxone as second line management of community acquired 
infections such as pneumonia and meningitis. There are also local guidelines for surgical prophylaxis but 
these are not considered adequate and are currently being updated. 
 
2.5 Variables 
Because the study was mainly descriptive and aimed to study patterns of antibiotic use, the following 
indicators were key outcome measures of interest: 
x Percentage of use of any antibiotic in the entire hospital and in the different wards. 
x Percentage of use of the various types of antibiotics in the entire hospital and various wards. 
x The number of antibiotics prescribed for each patient. 
x Prevalence of prescribing according to local guidelines where they exist. 
x Irrational prescribing, defined as the wrong dose 
x Prevalence of empiric antibiotic use as depicted by the frequency of requesting for sensitivity 
analyses 
 
2.6 Statistical analysis 
Statistical analysis was conducted using Stata version software 13. Categorical data was summarized as 
counts and percentages. Differences in antibiotic use and indications between the wards were compared 
using Chi-VTXDUHWHVWRU)LVKHU¶VH[DFWWHVWV 
 
2.7 Ethical considerations 
Approval to carry out the research was obtained from Kenyatta National Hospital/University of Nairobi 
Ethics and Research committee in May 2017 (letter Ref No. KNH-ERC/A/155) and Jaramogi Oginga 
Odinga Teaching and Referral Hospital Research and Training Committee in June 2017 (approval letter 
Ref No. ERC.1B/VOL.1/339). 
 
3. RESULTS 
 
The sampled departments had a total of 414 beds. The surgical ward had the highest number of beds 
(26.6%, n=110), followed by medical ward (23.9%, n=99). The sampled wards had total bed occupancy of 
65%. Most of the participants were aged between 20-64 years (58.2%, n=106), with a mean age of 26.9 
years. More than half of the participants were female (62.1%) (Table 1). 
 
Table 1: Baseline characteristics of participants on antibiotics at Jaramogi Oginga Odinga Teaching 
and Referral Hospital 
Characteristic  n (%) 
   
 <5 35 (19.2) 
 5-12  13 (7.1) 
Age (years) 13-19 14 (7.7) 
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 20-64 106 (58.2) 
 >65 14 (7.7) 
Sex  Male 69 (37.9) 
  Female 113 (62.1) 
  Medical 36 (19.8) 
  Surgery 52 (28.6) 
  Pediatrics 27 (14.8) 
Wards  Newborn unit 10 (5.5) 
  ICU 2 (1.1) 
  Gynecology 18 (9.9) 
  Post-natal  37 (20.3) 
 
On the days of the survey, there were 269 patients admitted in the hospital. A total of 182 patients 
(67.7%) were receiving one or more antibiotics. The prevalence was highest in the post-natal ward 
(92.5%, n=37) followed by the newborn unit, the intensive care unit, medical and gynecology wards 
(Table 2). 
 
Table 2:  Prevalence of antibiotic use in Jaramogi Oginga Odinga Teaching and Referral Hospital 
Patient 
characteristics 
Number 
of patients 
(n = 269) 
Patient on  
antibiotics 
(n = 182) 
Prevalence 
(%) 
Post-natal 40 37 92.5 
Newborn unit 12 10 83.3 
Intensive care unit 3 2 66.7 
Medical 56 36 64.3 
Gynecology 28 18 64.3 
Surgical 84 52 61.9 
Pediatrics 46 27 58.7 
Totals 269 182 67.7 
 
The 182 treated patients received a total of 333 antibiotic drugs (an average of 1.8 per patient). 7.1% in 
this study had HIV/AIDS recorded in their notes. 
 
Antibiotics were used either prophylactically or therapeutically. Prophylactic use was more common than 
for therapeutic use (Table 3). The most common anatomical site for prophylactic use was gynaecology 
(35.1%), followed by no defined site and the central nervous system. In the case of non-anatomic sites, 
antibiotics were used for medical prophylaxis in general without targeting a specific site. 
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Table 3: Distribution of antibiotic use by anatomic site  
                  Use of antibiotics 
 
Total 
(n=194) 
n(%) 
Prophylaxis 
(n=111)  
n(%) 
Treatment 
(n=83)  
n(%) 
 
Systems with the highest prevalence of  use (>10%) 
 
No defined site 33 (17.0) 17 (15.3) 16 (19.3) 
Gynecological 42 (21.7) 39 (35.1) 3 (3.6) 
Respiratory tract 26 (13.4) 2 (1.8) 24 (28.9) 
Central nervous system    25 (12.9) 16 (14.4) 9 (10.8) 
Skin, soft tissue, bone and joints 21 (10.8) 9 (9.8) 12 (14.5) 
Gastro-intestinal tract 20 (10.3) 12 (10.8) 8 (9.6) 
Neonatal 12 (6.2) 10 (9.0) 2 (2.4) 
 
Systems with the lowest prevalence of  use (<10%) 
 
Urinary tract 8 (4.1) 2 (1.8) 6 (7.2) 
Ear, nose and throat 3 (1.6) 2 (1.8) 1 (1.2) 
Eye 2 (1.0) 1 (0.9) 1(1.2) 
Cardiovascular system 2 (1.0) 1 (0.9) 1(1.2) 
NB: The denominator refers to the total frequency of antibiotic use among all anatomic sites 
 
Patients on antibiotic treatment were mainly diagnosed with respiratory tract infections (28.9%) followed 
by no defined site of infection (19.3%) and skin, soft tissues, bone and joints infections (14.5%). The most 
common indication for antibiotic use was medical prophylaxis (29%) (Figure 1).  
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Figure 1: Distribution of patients on antibiotic treatment by indications 
 
 
The relative frequency of each indication for antibiotic use varied among the different types of wards 
(Figure 2). The most common indication for antibiotic use among patients on the medical ward was for the 
treatment of community-acquired infection (55%), whereas surgical prophylaxis was the most common 
indication for antibiotic use in the surgical wards (67.9%). Medical prophylaxis was the main indication of 
antibiotic use in postnatal ward (32.8%), with medical prophylaxis the only indication in the newborn unit 
(100%). Fewer than 70% of patients in the surgical ward were prescribed antibiotics for surgical 
prophylaxis. The average number of antibiotic doses for surgical prophylaxis was 19.1 
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Figure 2: Distribution of patients on antibiotics treatment by indication stratified by hospital wards 
 
 
Antibiotics with a high frequency of use were third generation cephalosporins (55%), imidazole derivatives 
(41.8%), broad-spectrum penicillins (41.8%) and aminoglycosides (7.1%) (Figure 3). The prescribing of 
third generation cephalosporins was appreciably higher in the pediatric ward compared with other 
antibiotics (92.6% of total use, p< 0.01) and lower in the newborn unit (10%, p < 0.0.1) versus other 
antibiotics. There was relatively high use of third generation cephalosporins in the surgical wards (55% of 
the total number of surgical patients on antibiotics; n=29)). The majority of antibiotics prescribed in the 
postnatal ward were imidazole derivatives including metronidazole (86.5%, p < 0.01), attributed to a high 
frequency of mixed anaerobic and aerobic infections in this setting, as well as broad spectrum penicillins 
(81.1%, p< 0.01). Aminoglycoside use was mainly in the newborn unit (80%, p< 0.01). 
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Figure 3: Distribution of high frequency use antibiotics across the wards (some participants 
received more than one antibiotic) 
 
 
The total prescribed daily doses of the all most frequently prescribed oral antibiotics were found to be 
optimal when compared to daily doses recommended by United Kingdom British National Formulary (UK 
BNF). The prescribed daily dose of ceftriaxone was higher than maximum daily dose recommended by 
UK BNF at 6000 mg. The other parenteral antibiotics including benzyl penicillin (4800 mg), flucloxacillin 
(4000mg), gentamicin (390mg), metronidazole (1500mg), co-amoxiclav (2400 mg), meropenem (1500mg) 
and ceftazidime (900mg) had normal daily doses when compared to those recommended by the UK BNF. 
Most of the antibiotics were prescribed three times a day (37.2%) followed by twice a day (27.9%) as 
shown in Table 4.  However, 1.5% of prescriptions had no frequency indicated. The most common route 
of administration was intravenous (63.1%), with the oral route accounting for 32.4% of use. The most 
frequent duration of use was between 5-7 days (73.6%) followed by 1 to 4 days (13.8%). 5.7% of 
prescriptions had no duration indicated. 
 
Table 4: Frequency, route of administration and duration of antibiotic use 
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Frequency 
Not indicated 5 (1.5) 
STAT 14 (4.2) 
Once daily 65 (19.5) 
Twice daily 93 (27.9) 
Three times a day 124 (37.2) 
Four times a day 32 (9.6) 
 Not indicated 3 (0.9) 
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4.  DISCUSSION 
 
67.7% of patients admitted at JOOTRH were on antibiotics, similar to a previous study undertaken in 
Kenya among inpatients in Kenya [14] This may suggest over prescribing of antibiotics, compared to  
several studies in Europe which report the prevalence of antibiotic use in hospitals between 25-35%. [50-
53]. The differences may be due to well developed antimicrobial stewardship programmes in Europe. 
However, this needs to be investigated further before any definitive statements can be made, given the 
high prevalence of infectious diseases in sub-Sahara Africa including HIV as well as multi-drug resistant 
organisms [33,37,41,54]. As mentioned, 7.1% of patients had HIV/ AIDS. However, this is likely to be an 
under-estimate as patients may be unwilling to divulge their status similar to other studies in Africa [45]. 
The most common indication for antibiotic use was medical prophylaxis, followed by community acquired 
infections, surgical prophylaxis and hospital acquired infections (Figure 2). This is different from other 
studies conducted among European hospitals that showed community acquired infections were the most 
common indication for antibiotic use [51-52]. This may indicate prophylactic treatment for patients with or 
suspected to have HIV/ AIDS. In addition, high prophylactic use of broad spectrum penicillins and 
imidazole derivatives in the postnatal ward is in accordance with local gynecological guidelines 
recommending antibiotics for prophylaxis in mothers after delivery [47]. Similarly, a high use of antibiotic 
prophylaxis in neonates is in line with guidelines in neonates with birth asphyxia and low body weight at 
birth [48]. 
 
Fewer than 70% of patients in the surgical ward were prescribed antibiotics for surgical prophylaxis, and  
the average number of antibiotic doses administered was 19.1. This is appreciably higher than the WHO 
and other recommendations, which indicate the use of just one dose administered up to one to two hours 
before the first incision [55-57]. These findings are a cause of concern because prolonged use of 
antibiotics for surgical prophylaxis may lead to adverse drug reactions and promote antibiotic resistance. 
Educational interventions are now required in the hospital to address this and promote more rational use 
of antibiotics among surgical patients. There is also concern with the high use of third generation 
cephalosporins in particular ceftriaxone in surgical ward (Figure 3) as ceftriaxone is not indicated for 
surgical prophylaxis [55,56,58,59]. This needs to be investigated further considering that none of the local 
guidelines advocate for the use ceftriaxone for surgical prophylaxis. This is further supported by the fact 
that there were no cases of pneumonia, septicemia or meningitis in the surgical ward that could warrant 
the prescribing of ceftriaxone.  
 
The most commonly prescribed classes of antibiotics were third generation cephalosporins, imidazole 
derivatives and broad spectrum penicillins (Figure 3), consistent with a published study in Egypt [16]. The 
high prevalence of use of third generation cephalosporins in the pediatric ward (Figure 3) could be 
attributed to the fact that pediatric patients tend to have a high prevalence of serious infections such as 
pneumonia and meningitis compared to adults. The high consumption of third generation cephalosporins 
in the medical ward could also be explained by the fact that patients admitted to this ward have a high 
prevalence of infections, with community acquired infections (55%, p < 0.001) the most common 
indication for administering antibiotics in the medical ward (Figure 2).  The overall widespread  use of 
third generation cephalosporins in the hospital reflects their tendency to be used for empiric management 
of serious infections, influenced by the fact that clinicians and nurses find their frequency of dosing 
convenient. They can be administered once or twice a day compared to the first line agents such as 
benzyl penicillin, which have to be administered every six hours. This needs to be investigated further 
 
Route 
Oral 108 (32.4) 
Intravenous 210 (63.1) 
Intramuscular 9 (2.7) 
Topical 3 (0.9) 
 
 
Duration of use (days) 
Not indicated 19 (5.7) 
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since, as mentioned, local guidelines advocate for the use of third generation cephalosporins as second 
line for the management of community acquired infections since earlier use of third generation 
cephalosporins will increase resistance rates [49]. 
 
Assessment of total daily doses of the most frequently prescribed oral antibiotics were found to be optimal 
when compared to those recommended by UK BNF. This shows prescribers are able to use the BNF 
effectively and keep up to date with prescribing information that is relevant to their clinical practice. In the 
case of parenteral antibiotics, there is minimal deviation from the prescribed UK BNF daily doses except 
ceftriaxone. The recommended maximum daily dose of ceftriaxone is 4000mg while the clinicians 
prescribed a total daily dose of 6000mg.This is a cause of concern given that ceftriaxone was the most 
frequently prescribed antibiotic and overdosing leads to increased treatment costs. Consequently, this 
should also be investigated further,  and protocols put in place to enhance earlier de-escalation of 
intravenous antibiotics to oral. 
 
The most common route of administration was intravenous (63.1%, n=210) with the intramuscular route 
accounting for 2.7%.  Overall, the percentage of encounters with an injectable antibiotic was 65.8%. This 
was consistent with another study in Democratic Republic of Congo which reported similar findings (68%) 
[60]. There might though represent excessive use of parenteral antibiotics in this facility. However, we did 
not analyze whether parenteral use of the antibiotics was rational or not, which will be the subject of 
future research. Parenteral antibiotics are generally indicated for unconscious patients, critically ill 
patients, those who are nil by mouth and those who are vomiting. It has been noted in many studies that 
prescribers persist in recommending parenteral use even when a patient can take medicines orally. The 
highest prevalence of parenteral use of antibiotics was in paediatric ward and newborn unit where over 
94% of antibiotics were administered parenterally. These findings are consistent with a study done in 
Ghana [61]. This could be explained by the fact that most paediatric patients are not cooperative and 
suffer from serious conditions that warrant parenteral administration. In other settings, paediatric 
outpatient parenteral treatment with antibiotics is widely practiced [62].   
 
The average duration of prescribed antibiotics was 5.6 days in our study. The current recommended 
optimal duration of treatment is usually 7-10 days as a short duration of treatment may lead to longer 
hospital stay and increase resistance to antibiotics. We will be exploring this further in future research. 
 
This is the first point prevalence survey of antibiotic use in Jaramogi Oginga Odinga Teaching and 
Referral Hospital in Western region of Kenya.  The information gained from this survey will help to 
formulate policies and guidelines in this hospital and wider in Kenya to improve future antibiotic use in 
hospitals and limit the spread of resistance. This is already happening. 
 
Limitations to this study include the fact that because the nurses strike started in May 2017 and was 
continuing, many patients were being discharged from the wards during time of survey and bed 
occupancy was below the usual level. As a result, files for patients in medical, gynecology and postnatal 
ward were located using the occurrence book and retrieved from the wards and health records 
department afterwards. Secondly, records for some patients were incomplete. This was managed by 
asking the attending clinician to clarify any missing information on the patientV¶ records where they could. 
Some patient records were missing and could not be traced. However, these limitations apply generally to 
PPS studies. There was also a low number of requests for sensitivity testing perhaps reflecting the time 
taken for the findings to be analysed and communicated. Despite this, we believe our findings are robust 
and we also believe this is the first comprehensive PPS study in this part of Kenya and generally among 
referral hospitals in Kenya. Lastly, universal sampling was also a strength, improving the generalizability 
of this study. Lastly, this study was able to give some insight into antimicrobial resistance patterns in the 
Western region of Kenya to guide future practice. 
 
5. CONCLUSIONS 
 
The actual dosing of antibiotics seemed appropriate when assessed against current guidance. However, 
there were areas of concern. There was high prevalence of antibiotic use, although there may be good 
reasons for this such as prophylaxis for patients with HIV/ AIDS and in motherspost delivery.Third 
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generation cephalosporins were also extensively used, in particular ceftriaxone, which needs addressing 
especially for surgical prophylaxis and the management of community acquired infections. Treatment of 
bacterial infections is also currently mainly empiric, which is a concern given high levels of resistance to 
certain antibiotics. Finally, surgical wards should be one a key target area of for educational interventions 
to promote rational antibiotic use given concerns with the length of surgical prophylaxis and current 
antibiotic use. Future developments should also include the instigation of formularies and antimicrobial 
stewardship programmes involving all key stakeholder groups including surgeons.  
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